VeriMomVeriMom

kaempferol rhamnoside é seguro durante a gravidez?

No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for kaempferol 3‑rhamnoside (Afzelin, CAS 482-39-3). ECHA substance information shows only company notifications for irritation endpoints (no H360/H361 harmonised classification). Peer‑reviewed literature for this compound reports pharmacology/toxicity studies (neuroprotective, metabolic) but no reproductive or teratology data, so there is no evidence of reproductive hazard. Low dermal/systemic absorption is expected for a polar flavonol glycoside in topical use, so exposure from normal cosmetic topical use is judged low but measurable. Sources: ECHA substance page, PubChem entry, PubMed studies.

Ingredientes
kaempferol rhamnoside
SEM RISCOS CONHECIDOS
93
/100
0

Related ingredients

Frequently asked questions

kaempferol rhamnoside é seguro durante a gravidez?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for kaempferol 3‑rhamnoside (Afzelin, CAS 482-39-3). ECHA substance information shows only company notifications for irritation endpoints (no H360/H361 harmonised classification). Peer‑reviewed literature for this compound reports pharmacology/toxicity studies (neuroprotective, metabolic) but no reproductive or teratology data, so there is no evidence of reproductive hazard. Low dermal/systemic absorption is expected for a polar flavonol glycoside in topical use, so exposure from normal cosmetic topical use is judged low but measurable. Sources: ECHA substance page, PubChem entry, PubMed studies.
kaempferol rhamnoside é seguro durante a amamentação?
No data indicate reproductive or lactation-specific toxicity or endocrine disruption for afzelin. With low expected dermal absorption for the glycoside, maternal systemic exposure from cosmetic topical use would likely be low; therefore transfer to breastmilk is unlikely but not studied.
kaempferol rhamnoside é seguro para a pele do bebê?
No infant-specific safety or developmental toxicity data were found. The compound is a flavonol glycoside (polar) and not known to be a developmental toxicant; hazard is therefore scored 0. Because infant skin has an immature barrier and higher surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2) to reflect higher potential per‑kg absorption if applied to baby skin.
Como o VeriMom pontua kaempferol rhamnoside?
O VeriMom pontua kaempferol rhamnoside em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
Quais são as alternativas seguras a kaempferol rhamnoside na gravidez?
Veja nossa lista curada de alternativas seguras a kaempferol rhamnoside com base em função semelhante e classificação sem riscos conhecidos.

Verifique qualquer rótulo em 2 segundos

Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.

Aviso Médico

Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.

Tenha a experiência completa no app VeriMom